# Review log: notes/chapters/IN-13-E.json (Genetic Skin Conditions)

Reviewer pass, Phase 1. Independent review against Robbins, Lippincott Biochemistry, Junqueira, Abbas, Lange Pathophysiology of Disease. No ERRORs from tools/check_notes.py before or after; chapter length not increased (prose fell from 2,834 to 2,787 words).

## Accuracy corrections
- OCA1B table row conflated OCA1B with the temperature sensitive OCA1 variant; rewritten so pigment accumulation with age and the temperature sensitive variant that pigments only cooler regions are named separately.
- Removed the duplicate temperature sensitive description from the OCA1 prose, which also eliminated repetition with the table.
- Chediak-Higashi: replaced "bleeding time is prolonged" (an obsolete test) with impaired platelet aggregation and mucocutaneous bleeding at a normal platelet count, which is the mechanism the dense granule defect actually explains.
- Vascular Ehlers-Danlos: "Wall tension rises with the product of transmural pressure and radius divided by wall thickness" misnamed the quantity; corrected to wall stress equals pressure times radius divided by wall thickness.
- Flow step corrected to "Wall stress from pressure and radius exceeds wall strength" for consistency with the corrected physics.
- Iris transillumination definition said the pupil glows red; corrected to light reflected from the fundus passing outward through an unpigmented iris, seen on slit lamp retroillumination.
- Overview intro softened from "the developing visual pathway never forms correctly" to "does not develop normally", since foveal hypoplasia and chiasmal misrouting are graded rather than absolute.
- Source entry for Lange Pathophysiology of Disease changed to real chapter names, "Genetic Disease; Diseases of the Skin".
- Dropped the Moore Clinically Oriented Anatomy entry; the "Introduction, skin and fascia" section supports nothing in this chapter, leaving five honest sources.

## Scope (Part I only)
- STOP prompt in the Ehlers-Danlos findings section asked which patient "needs vascular imaging", which is management; rewritten to ask which patient carries the risk of arterial rupture and which collagen explains it.
- Flow caption rewritten from "the absence of aneurysm on prior imaging does not lower the risk" to "arterial dilation need not precede it", removing the imaging reference while keeping the mechanistic point.
- Removed "sutures pull through" from the skin fragility paragraph, a surgical detail outside Part I.

## Teaching quality and spec compliance
- Overview connections reduced from six to five to meet the 3 to 5 rule; the musculoskeletal and wound healing links were merged, since scar strength in all four disorders turns on the same type I fibril assembly and cross-linking.
- Split the six sentence Chediak-Higashi paragraph into two, separating the pigment defect from the immune, platelet, and neural consequences.
- Split the seven sentence Ehlers-Danlos molecular paragraph so the classic type V defect and the vascular type III defect each stand alone.
- Tightened the subtype paragraph in the collagen section and removed the empty transition sentence "Because assembly runs through many steps, a defect at any one of them produces a recognizable disease", which the flow caption already says.
- Condensed the list of vascular type III events and the pressure point findings, which were restated in the subtype table and the summary.
- Removed the restatement of the nine point Beighton scale from prose, since the overview term already defines it.

## Verified as correct, no change
- Tyrosinase as a copper enzyme catalyzing both tyrosine to DOPA and DOPA to dopaquinone; catecholamine synthesis via tyrosine hydroxylase being unaffected.
- OCA2 (P protein) as the most common form worldwide, OCA3 (TYRP1) rufous pigment, OCA4 (SLC45A2) frequency in Japanese populations.
- X-linked ocular albinism from GPR143 with mottled fundus in carriers; Hermansky-Pudlak as a lysosome related organelle biogenesis defect with platelet storage pool bleeding, pulmonary fibrosis, and granulomatous colitis; piebaldism from KIT.
- Phenylketonuria pigment dilution by both loss of tyrosine supply and phenylalanine inhibition of tyrosinase.
- Collagen pathway cofactors (oxygen, alpha-ketoglutarate, ferrous iron, vitamin C), propeptide cleavage to tropocollagen, copper dependent lysyl oxidase; type V collagen nucleating and limiting type I fibril diameter; PLOD1 lysyl hydroxylase 1 in the kyphoscoliotic type; ADAMTS2 in dermatosparaxis; N-propeptide cleavage site mutations in the arthrochalasia type.
- Urine lysyl pyridinoline to hydroxylysyl pyridinoline ratio as the kyphoscoliotic clue in the worked example (already flagged in verify).
- Marfan FBN1 with latent transforming growth factor beta sequestration, aortic root dilation, upward lens subluxation; homocystinuria with downward subluxation; osteogenesis imperfecta COL1A1 and COL1A2 dominant negative with blue sclerae from thin sclera.

## Items moved to or kept in verify
No new items added and none removed; the seven existing entries were checked and remain honest (Ehlers-Danlos subtype naming and count, albinism subtype prevalence, acuity range, melanocyte to keratinocyte ratio, which named syndromes NABNE tests, whether laboratory cross-link testing is in Part I scope, and the two requested diagram names).

## Checker
`python3 tools/check_notes.py notes/chapters/IN-13-E.json`: 0 errors, 2 warnings. Both warnings are section word counts that include full table text (C03 670, C04 691); prose per competency is 431 to 455 words and total chapter prose is 2,787, inside the spec limits.
